The latest in Contract Research Organizations now live on 20/20 Pharma

Top Quote Bayer's Suzanne Besaw heads this discussion on the current trends in contract research organizations, specifically lab services, with Rob Danziger of Medpace Reference Laboratories, Jody Fleisig of ICON Central Laboratories and Jeff Mayhew of LabConnect. End Quote
  • New York, NY (1888PressRelease) July 06, 2011 - Industry experts go head to head in 20/20 Pharma's 'CRO's - Focus on laboratories' podcast discussion. This discussion covers all the latest trends for CRO's, which provide outsourced pharmaceutical research support to pharmaceutical and biotechnology industries. The podcast is available to download free at:

    The podcast is moderated by Suzanne Besaw, Alliance Manager for R&D Services in Bayer Healthcaare Procurement at Bayer, who is joined by three industry experts: Rob Danziger of Medpace Reference Laboratories, Jody Fleisig of ICON Central Laboratories and Jeff Mayhew of LabConnect.

    The podcast is an insightful analysis of Contract Research Organizations and includes comments on:
    - The impact on your business when choosing one or two strategic labs
    - Advantages strategic partnering can offer a sponsor company
    - The impact of rising fuel costs on shipping and couriers
    - Back up plans and parameters put in place to deal with natural disasters
    - Hurdles in obtaining, shipping and testing lab samples in emerging markets

    In the podcast Rob Danziger said: "The trend that we are starting to see with some of the major Pharmas is they are going to a single sole source longer contract and time will tell if these asset purchases work.

    "It may make good sense from a business perspective but it is really providing the best lab options and the best science options to support development of those drugs."

    Jody Fleisig of ICON Central Laboratories also commented: "One of the major benefits to working with the preferred provider relationship or a strategic relationship is it allows standardization and measurement."

    For more information and topical pharmaceutical related podcasts visit

    About 20/20 Pharma
    20/20 Pharma is a product of IMI Publishing Ltd, dedicated to offering its clients and partners a unique opportunity to not only advertise the capabilities of their companies, but also showcase their technology or services through in-depth educational pieces and targeted online events.

    Dedicated to being a trusted and authoritative resource within top pharmaceutical companies, as well as small, specialty and biotech businesses, 20/20 Pharma bridges the gap between the industry's top issues and the solutions that top-tier vendors can provide.

    Contact details
    Pinar Gencturk
    Managing Editor, 20/20 Pharma
    +44 207 148 5152 | pgencturk ( @ ) imipublishing dot com

  • FB Icon Twitter Icon In-Icon
Contact Information